Effectiveness of BNT162b2 Formulations Using State Vaccine Registry and Insurance Claims Data

Clinical trial NCT06199934 · COMPLETED

Trial details

NCT number: NCT06199934
Sponsor: Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

SARS-CoV-2 COVID-19 Vaccines

Start date: 2023-09-11
Primary completion: 2024-07-31
Enrollment: 19853610

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.